Monday, November 25, 2024
11/25/2024
WellSpan Medication Assisted Treatment (WSMAT) will expand and enhance access to MAT services for persons with an Opioid Use Disorder (OUD) seeking or receiving MAT in the south-central Pennsylvania region. WSMAT will increase the number of DEA-X prescribers, expand entry points, use Evidence Based Practices, improve support and education for pregnant OUD patients, and create workflows that support increased access to treatment for 1200 new (400 new patients in each grant year) MAT patients by 9/29/2021. The target population is patients with opioid use disorder (OUD) who live in the Adams, Franklin, Lancaster, Lebanon, or York counties and are receiving medication-assisted treatment (MAT) and recovery support through WellSpan (WS), Family First Health (FFH), The RASE Project or Lancaster Health Center (LHC). The 3,552-square mile area is home to 1,365,130 people of which 1,014,071 are age 20+. Ten percent have no health insurance, 53% live below poverty level, 10% are veterans, 9% identify as Hispanic, 90% are white, 5% black, and 2% Asian. WellSpan (WS) recognizes the devastating impact the epidemic of opioid use has made on the south-central Pennsylvania. WS has been surveilling the opioid crisis closely and deploying significant time and resources to address the problem. Leadership teams are intimately involved in Heroin Task Forces across all counties we serve, and have worked to gather data, share best practices, and implement innovative models of care. WS has forged relationships with community organizations who partner to support patients and families affected by OUD. The goal of the WSMAT project is to expand and enhance access to Medication Assisted Treatment(MAT) services for persons with an Opioid Use Disorder seeking or receiving MAT. As a result of this project the following will be accomplished: 1) increased number of DEA-X waivered prescribers to 50, 2) 1200 new patients with OUD initiating MAT in combination with comprehensive OUD psychosocial services; 3) increased screening of WS patients receiving physical and/or behavioral health services for OUD in at least 5 primary care practices, 10 behavioral health practices, and at least 3 WS acute care hospitals; 4) increased screening for OUD and recovery support; 5) increased screening for communicable diseases, co-occurring mental health conditions, and other substance abuse disorders); 6) expanded points of entry for vulnerable patients through direct partnership with 2 area prisons that will result in at least 20 released individuals being provided with MAT and recovery support services; 7) implementation of the Yale-protocol in at least two WS acute care hospitals, 8) 80% of participants in program 6 months+ decrease opioid abuse.
HHS’ Tracking Accountability in Government Grants System (TAGGS) website provides access to detailed descriptions of grants, loans, aggregated direct payments and other types of financial assistance awarded by the HHS Operating Divisions (OPDIVs) and the Office of the Secretary Staff Divisions (STAFFDIVs).
